FORA Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-65,810
Closed -$3.06M 614
2023
Q2
$3.06M Buy
+65,810
New +$2.27M 0.43% 67

FORA Capital's DICE Position: Q3 2023 in Review

FORA Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 65,810 shares — an estimated $3.06M sold.

FORA Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $3.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • FORA Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • FORA Capital sold 65,810 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.06M.
  • FORA Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • FORA Capital's DICE Therapeutics, Inc. Common Stock position peaked at $3.06M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on FORA Capital's 13F filing for Q3 2023, filed 13 Nov 2023.